《关于“一项评估普芦卡必利治疗小儿功能性便秘疗效和安全性的3期随机双盲安慰剂对照研究的设计”的勘误》[当代临床试验通讯 33 (2023) 101144]
Corrigendum to "Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation" [Contemp. Clin. Trials Commun. 33 (2023) 101144].
作者信息
Cuffari Carmen, Spalding William, Achenbach Heinrich, Thakur Manoj, Gabriel André
机构信息
Children's National Hospital, Division of Gastroenterology, Hepatology and Nutrition, Washington, DC, USA.
Takeda Development Center Americas, Inc., Lexington, MA, USA.
出版信息
Contemp Clin Trials Commun. 2024 Apr 27;39:101302. doi: 10.1016/j.conctc.2024.101302. eCollection 2024 Jun.
Abstract
[This corrects the article DOI: 10.1016/j.conctc.2023.101144.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.conctc.2023.101144。]
相似文献
1
Corrigendum to "Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation" [Contemp. Clin. Trials Commun. 33 (2023) 101144].《关于“一项评估普芦卡必利治疗小儿功能性便秘疗效和安全性的3期随机双盲安慰剂对照研究的设计”的勘误》[当代临床试验通讯 33 (2023) 101144]
Contemp Clin Trials Commun. 2024 Apr 27;39:101302. doi: 10.1016/j.conctc.2024.101302. eCollection 2024 Jun.
2
Corrigendum to "Approach bias retraining to augment smoking cessation: Study protocol for a randomized controlled trial" [Contemp. Clin. Trials Commun. 14 (2019) 100340].《“采用趋近偏向矫正训练以增强戒烟效果：一项随机对照试验的研究方案”的勘误》[当代临床试验通讯 14 (2019) 100340]
Contemp Clin Trials Commun. 2022 May 6;28:100922. doi: 10.1016/j.conctc.2022.100922. eCollection 2022 Aug.
3
Corrigendum to "Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial" [Contemp. Clin. Trials Commun. 12 (2018) 109-115].《提高乳腺癌患者内分泌激素治疗依从性：一项随机对照试验的研究方案》的勘误[当代临床试验通讯 12 (2018) 109 - 115]
Contemp Clin Trials Commun. 2019 Mar 17;14:100349. doi: 10.1016/j.conctc.2019.100349. eCollection 2019 Jun.
4
Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233].《L-丝氨酸补充剂对GRIN2B功能丧失突变儿童的有效性：单病例（n-of-1）多次交叉试验的原理与方案》的勘误[当代临床试验通讯36（2023年）/ DOI: 10.1016/j.conctc.2023.101233]
Contemp Clin Trials Commun. 2024 Feb 1;38:101264. doi: 10.1016/j.conctc.2024.101264. eCollection 2024 Apr.
5
Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18].《北美三级护理中心儿科住院患者常规护理辅助治疗中儿科综合医学的比较效果：一项实用整群对照试验的研究方案》勘误 [当代临床试验通讯（2017）12 - 18]
Contemp Clin Trials Commun. 2017 Apr 21;6:147. doi: 10.1016/j.conctc.2017.04.004. eCollection 2017 Jun.
6
Corrigendum to 'A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults' [Contemp. Clin. Trials Commun. 10 (2018) 169-176].《认知行为疗法与瑜伽治疗老年焦虑症患者担忧的随机偏好试验》勘误 [当代临床试验通讯 10 (2018) 169 - 176]
Contemp Clin Trials Commun. 2020 Jan 3;19:100517. doi: 10.1016/j.conctc.2020.100517. eCollection 2020 Sep.
7
Corrigendum to "The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials" [Contemp. Clin. Trials Commun. 16 (2019) 100443].《系统评价与荟萃分析的巨大成本：呼吁机器学习更多参与以评估临床试验前景》的勘误 [当代临床试验通讯 16 (2019) 100443]
Contemp Clin Trials Commun. 2019 Sep 12;16:100450. doi: 10.1016/j.conctc.2019.100450. eCollection 2019 Dec.
8
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation.一项评估普芦卡必利治疗小儿功能性便秘疗效和安全性的3期随机双盲安慰剂对照研究的设计
Contemp Clin Trials Commun. 2023 Apr 30;33:101144. doi: 10.1016/j.conctc.2023.101144. eCollection 2023 Jun.
9
Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.普芦卡必利治疗慢性便秘的疗效与安全性：六项随机对照临床试验的综合分析
Dig Dis Sci. 2016 Aug;61(8):2357-2372. doi: 10.1007/s10620-016-4147-9. Epub 2016 Apr 7.
10
A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.一项随机、双盲、安慰剂对照的3期试验，旨在评估普芦卡必利治疗慢性便秘男性患者的疗效、安全性和耐受性。
Am J Gastroenterol. 2015 May;110(5):741-8. doi: 10.1038/ajg.2015.115. Epub 2015 Apr 14.
Zotero 插件